Modulation of Anti-tumor Immunity and Tumor Microenvironment
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Immunology and Immunotherapy".
Deadline for manuscript submissions: closed (30 April 2024) | Viewed by 119
Special Issue Editor
2. Senior Attending Physician, Department of Radiation Oncology, MacKay Memorial Hospital, Taipei, Taiwan
3. Director, Laboratory of Cancer Therapeutics, MacKay Memorial Hospital, Taipei, Taiwan
4. Professor, Department of Artificial Intelligence and Medical Application, MacKay Junior College of Medicine, Nursing and Management, Taipei, Taiwan
5. Professor, School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan
Interests: cancer immunology; radiation oncology; radiation biology; natural product
Special Issue Information
Dear Colleagues,
In cancer treatment, immunotherapy has demonstrated promising clinical efficacy for the improvement of survival and quality of life. The success of immunotherapy in individual patients greatly depends on the state of anti-tumor immunity and tumor microenvironment. In clinical practice of cancer therapy, the combination of various treatment modalities remains an important strategy, such as the application of immunotherapy, chemotherapy, target therapy, hyperthermia and radiotherapy, etc. However, the impact of various therapeutic modalities on anti-tumor and tumor microenvironments remains to be clarified. It remains a research challenge and an unmet medical need for better understanding alterations of anti-tumor immunity and the tumor microenvironment, especially the influences of various treatment modalities. Therefore, research on the modulation of anti-tumor and tumor microenvironments using various therapeutic modalities is important for further augmentation of cancer treatment outcomes.
For this Special Issue, we invite you to contribute original research articles, reviews, or shorter perspective articles on all aspects related to the theme of “Modulation of Anti-Tumor Immunity and Tumor Microenvironment". All research regarding basic, translational and clinical studies as well as development of new therapeutic agents or drug repositioning is welcome. Relevant topics include, but are not limited to, the following:
- Anti-tumor immunity;
- Tumor microenvironment;
- Immunotherapy;
- Chemotherapy;
- Target therapy;
- Hyperthermia;
- Radiotherapy;
- Novel therapeutic agents;
- Other treatment modalities.
Dr. Yu-Jen Chen
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- anti-tumor immunity
- tumor microenvironment
- immunotherapy
- chemotherapy
- target therapy
- hyperthermia
- radiotherapy
